BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26982343)

  • 1. Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma.
    Tayao M; Andrici J; Farzin M; Clarkson A; Sioson L; Watson N; Chua TC; Sztynda T; Samra JS; Gill AJ
    PLoS One; 2016; 11(3):e0150338. PubMed ID: 26982343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinoma.
    Mosbeh A; Halfawy K; Abdel-Mageed WS; Sweed D; Rahman MHA
    Cancer Genet; 2018 Aug; 224-225():21-28. PubMed ID: 29778232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.
    Andrici J; Jung J; Sheen A; D'Urso L; Sioson L; Pickett J; Parkhill TR; Verdonk B; Wardell KL; Singh A; Clarkson A; Watson N; Toon CW; Gill AJ
    Hum Pathol; 2016 May; 51():9-15. PubMed ID: 27067777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
    Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
    Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of expression of BAP1 is very rare in non-small cell lung carcinoma.
    Andrici J; Parkhill TR; Jung J; Wardell KL; Verdonk B; Singh A; Sioson L; Clarkson A; Watson N; Sheen A; Farzin M; Toon CW; Gill AJ
    Pathology; 2016 Jun; 48(4):336-40. PubMed ID: 27114369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
    Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice.
    Perkail S; Andricovich J; Kai Y; Tzatsos A
    Nat Commun; 2020 Jun; 11(1):3018. PubMed ID: 32541668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of BAP1 Expression Occurs Frequently in Intrahepatic Cholangiocarcinoma.
    Andrici J; Goeppert B; Sioson L; Clarkson A; Renner M; Stenzinger A; Tayao M; Watson N; Farzin M; Toon CW; Smith RC; Mittal A; Samra JS; Hugh TJ; Chou A; Lawlor RT; Weichert W; Schirmacher P; Sperandio N; Ruzzenente A; Scarpa A; Gill AJ
    Medicine (Baltimore); 2016 Jan; 95(2):e2491. PubMed ID: 26765459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report.
    Ottenhof NA; de Wilde RF; Morsink FH; de Leng WW; Ausems MG; Morreau H; van Hillegersberg R; Offerhaus GJ; Milne AN
    Hum Pathol; 2012 Mar; 43(3):457-61. PubMed ID: 21992816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.
    Cao D; Zhang Q; Wu LS; Salaria SN; Winter JW; Hruban RH; Goggins MS; Abbruzzese JL; Maitra A; Ho L
    Mod Pathol; 2007 May; 20(5):570-8. PubMed ID: 17396143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.
    Shen C; Wang Y; Wei P; Du X
    BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of expression of BAP1 is a useful adjunct, which strongly supports the diagnosis of mesothelioma in effusion cytology.
    Andrici J; Sheen A; Sioson L; Wardell K; Clarkson A; Watson N; Ahadi MS; Farzin M; Toon CW; Gill AJ
    Mod Pathol; 2015 Oct; 28(10):1360-8. PubMed ID: 26226841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma.
    Lee HJ; Pham T; Chang MT; Barnes D; Cai AG; Noubade R; Totpal K; Chen X; Tran C; Hagenbeek T; Wu X; Eastham-Anderson J; Tao J; Lee W; Bastian BC; Carbone M; Webster JD; Dey A
    Cancer Res; 2020 Apr; 80(8):1656-1668. PubMed ID: 31988076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.
    Owen D; Sheffield BS; Ionescu D; Churg A
    Hum Pathol; 2017 Feb; 60():82-85. PubMed ID: 27984124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of annexin 1 in pancreatic cancer and its clinical significance.
    Bai XF; Ni XG; Zhao P; Liu SM; Wang HX; Guo B; Zhou LP; Liu F; Zhang JS; Wang K; Xie YQ; Shao YF; Zhao XH
    World J Gastroenterol; 2004 May; 10(10):1466-70. PubMed ID: 15133855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of BRCA1-associated protein 1 predicts unfavorable survival in gastric adenocarcinoma.
    Yan S; He F; Luo R; Wu H; Huang M; Huang C; Li Y; Zhou Z
    Tumour Biol; 2016 May; 37(5):6125-33. PubMed ID: 26611647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
    Valsecchi ME; Holdbrook T; Leiby BE; Pequignot E; Littman SJ; Yeo CJ; Brody JR; Witkiewicz AK
    BMC Cancer; 2012 Mar; 12():104. PubMed ID: 22436573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma.
    McGregor SM; Dunning R; Hyjek E; Vigneswaran W; Husain AN; Krausz T
    Hum Pathol; 2015 Nov; 46(11):1670-8. PubMed ID: 26376834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
    Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
    Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
    Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
    Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.